Biotest Aktiengesellschaft (BIO) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.114x

Based on the latest financial reports, Biotest Aktiengesellschaft (BIO) has a cash flow conversion efficiency ratio of -0.114x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-58.10 Million ≈ $-67.93 Million USD) by net assets (€509.60 Million ≈ $595.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Biotest Aktiengesellschaft stock valuation for the company's overall valuation and market capitalisation.

Biotest Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Biotest Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Biotest Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotest Aktiengesellschaft ranked by their cash flow conversion efficiency. Explore earnings quality score of Biotest Aktiengesellschaft to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Firefly Metals Ltd AU:FFM	-0.012x
Resolute Holdings Management, Inc. NYSE:RHLD	0.031x
Northwest Pipe Company NASDAQ:NWPX	0.072x
Guangdong Shaoneng Group Co Ltd SHE:000601	0.095x
Allianz Malaysia Bhd KLSE:1163	0.024x
Whitestone REIT NYSE:WSR	0.008x
Brookline Bancorp Inc NASDAQ:BRKL	0.027x
Canaccord Genuity Group Inc TO:CF	0.333x

Annual Cash Flow Conversion Efficiency for Biotest Aktiengesellschaft (2002–2024)

The table below shows the annual cash flow conversion efficiency of Biotest Aktiengesellschaft from 2002 to 2024. View Biotest Aktiengesellschaft (BIO) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€530.70 Million ≈ $620.44 Million	€60.90 Million ≈ $71.20 Million	0.115x	+2220.40%
2023-12-31	€498.90 Million ≈ $583.27 Million	€-2.70 Million ≈ $-3.16 Million	-0.005x	+95.04%
2022-12-31	€371.10 Million ≈ $433.85 Million	€-40.50 Million ≈ $-47.35 Million	-0.109x	-222.46%
2021-12-31	€380.40 Million ≈ $444.73 Million	€33.90 Million ≈ $39.63 Million	0.089x	+335.65%
2020-12-31	€441.60 Million ≈ $516.28 Million	€-16.70 Million ≈ $-19.52 Million	-0.038x	+46.32%
2019-12-31	€476.90 Million ≈ $557.55 Million	€-33.60 Million ≈ $-39.28 Million	-0.070x	+30.22%
2018-12-31	€495.20 Million ≈ $578.94 Million	€-50.00 Million ≈ $-58.46 Million	-0.101x	-202.38%
2017-12-31	€347.80 Million ≈ $406.61 Million	€34.30 Million ≈ $40.10 Million	0.099x	-46.02%
2016-12-31	€360.70 Million ≈ $421.70 Million	€65.90 Million ≈ $77.04 Million	0.183x	+97.71%
2015-12-31	€412.30 Million ≈ $482.02 Million	€38.10 Million ≈ $44.54 Million	0.092x	+489.25%
2014-12-31	€480.20 Million ≈ $561.40 Million	€-11.40 Million ≈ $-13.33 Million	-0.024x	-51.90%
2013-12-31	€460.70 Million ≈ $538.61 Million	€-7.20 Million ≈ $-8.42 Million	-0.016x	-116.63%
2012-12-31	€369.43 Million ≈ $431.91 Million	€34.73 Million ≈ $40.60 Million	0.094x	-54.92%
2011-12-31	€346.67 Million ≈ $405.29 Million	€72.28 Million ≈ $84.50 Million	0.208x	-17.59%
2010-12-31	€307.61 Million ≈ $359.63 Million	€77.83 Million ≈ $90.99 Million	0.253x	+115.51%
2009-12-31	€269.86 Million ≈ $315.50 Million	€31.68 Million ≈ $37.04 Million	0.117x	-13.75%
2008-12-31	€253.37 Million ≈ $296.22 Million	€34.49 Million ≈ $40.32 Million	0.136x	-5.47%
2007-12-31	€225.76 Million ≈ $263.94 Million	€32.51 Million ≈ $38.01 Million	0.144x	-1.85%
2006-12-31	€179.31 Million ≈ $209.64 Million	€26.31 Million ≈ $30.76 Million	0.147x	-12.46%
2005-12-31	€168.97 Million ≈ $197.55 Million	€28.32 Million ≈ $33.11 Million	0.168x	-28.46%
2004-12-31	€107.97 Million ≈ $126.22 Million	€25.29 Million ≈ $29.57 Million	0.234x	+46.49%
2003-12-31	€103.29 Million ≈ $120.75 Million	€16.52 Million ≈ $19.31 Million	0.160x	+619.93%
2002-12-31	€110.79 Million ≈ $129.53 Million	€2.46 Million ≈ $2.88 Million	0.022x	--

About Biotest Aktiengesellschaft

XETRA:BIO Germany

Market Cap

$976.15 Million

€834.96 Million EUR

Market Cap Rank

#9073 Global

#1155 in Germany

Share Price

€42.20

Change (1 day)

+0.00%

52-Week Range

€42.20 - €42.20

All Time High

€44.10